Long-term outcomes after switching from baricitinib 4 mg to upadacitinib 30 mg in atopic dermatitis: a 144-week retrospective study

Published: 8 May 2026| Version 1 | DOI: 10.17632/9xdkpxxd78.1
Contributors:
Teppei Hagino,
, Eita Fujimoto, Naoko Kanda

Description

Supplementary Methods Supplementary Table 1 Supplementary Table 2

Files

Categories

Medicine, Pharmacology, Dermatology, Clinical Research, Atopic Dermatitis

Licence